Aveanna Healthcare Holdings (AVAH) EBITDA (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has reported EBITDA for 7 consecutive years, with $71.0 million the latest figure, recorded in Q1 2026.

• EBITDA for Q1 2026 came in at $71.0 million, up 55.22% year-over-year; the trailing twelve-month figure through Jan 2026 was $256.5 million (up 83.47% YoY), and the FY2026 annual result was $266.3 million, up 78.24% from the prior year.
• EBITDA was $71.0 million for Q1 2026 at Aveanna Healthcare Holdings, up from $53.6 million in the prior quarter.
• Over five years, EBITDA peaked at $80.0 million in Q2 2025 and troughed at -$456.4 million in Q3 2022.
• Average EBITDA over 5 years is -$14.9 million, with a median of $29.3 million recorded in 2023.
• Year-over-year, EBITDA plunged 1694.99% in 2023 and soared 144.56% in 2024.
• Over 5 years, EBITDA stood at -$204.5 million in 2022, then soared by 114.33% to $29.3 million in 2023, then surged by 56.25% to $45.8 million in 2024, then climbed by 17.07% to $53.6 million in 2025, then soared by 32.59% to $71.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $71.0 million in Q1 2026, $53.6 million in Q3 2025, and $80.0 million in Q2 2025.